More on DNTH

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-31.1% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (2/13/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Dianthus Therapeutics (NQ:DNTH)
Delayed: 65.20 +3.77 (6.14%)
Prev. Close $61.43  
Open$60.16 
52 Wk High$ 
52 Wk Low$ 
Day High$65.50 
Day Low$60.16 
P/E N/A  
EPS$ 
Volume1,184,672 

Friends, Peers and Foes (?): TOI, ALNY, ARGX, BBIO, BIIB (more...)

Mar 4, 2026 05:10 AM Dianthus Therapeutics (DNTH) PT Raised to $200 at Guggenheim
Mar 3, 2026 04:01 PM Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 24, 2026 07:01 AM Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference
Feb 17, 2026 04:37 PM Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:26 PM Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 5, 2026 07:00 AM Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Feb 4, 2026 05:42 PM Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: CARR EDWARD
Feb 4, 2026 05:42 PM Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Veness Adam M
Feb 4, 2026 05:41 PM Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Randhawa Simrat
Feb 4, 2026 05:40 PM Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Savitz Ryan
View All Articles

Entities mentioned with DNTH

View All Entities